May Measurement Month 2020: An Analysis of Blood Pressure Screening Results From China
ABSTRACT We reported the blood pressure data obtained in the May Measurement Month (MMM) China project in 2020 during the COVID‐19 control period. The study participants were adults (≥ 18 years), ideally in whom blood pressure had not been measured in the previous year. Blood pressure was measured t...
Saved in:
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | The Journal of Clinical Hypertension |
| Subjects: | |
| Online Access: | https://doi.org/10.1111/jch.14919 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832576404291584000 |
|---|---|
| author | Xin Chen Li‐Ping Zhang Xiao‐Long Wang Ning‐Ru Zhang Jing Yu Li‐Ying Xu Tong‐She Li Hong Luan Juan Zhang Ya‐Min Hu Dan Liu Qi‐Dong Zheng Yan Li Ji‐Guang Wang |
| author_facet | Xin Chen Li‐Ping Zhang Xiao‐Long Wang Ning‐Ru Zhang Jing Yu Li‐Ying Xu Tong‐She Li Hong Luan Juan Zhang Ya‐Min Hu Dan Liu Qi‐Dong Zheng Yan Li Ji‐Guang Wang |
| author_sort | Xin Chen |
| collection | DOAJ |
| description | ABSTRACT We reported the blood pressure data obtained in the May Measurement Month (MMM) China project in 2020 during the COVID‐19 control period. The study participants were adults (≥ 18 years), ideally in whom blood pressure had not been measured in the previous year. Blood pressure was measured three times consecutively with a 1‐min interval in the sitting position, using a validated automated BP monitor (Omron HEM‐7081IT), and transmitted to a central database via a smartphone app. The measurement was performed at 136 sites across 29 China provinces. The 100 728 participants had a mean (±SD) age of 45.6 (±18.3) years and included 56 097 (55.7%) women. The mean systolic/diastolic blood pressure was 120.0/76.9 mm Hg. The proportion of hypertension was 28.9% (n = 29 135), and the awareness, treatment, and control rates of hypertension were 45.3% (n = 13 212), 39.7% (n = 1573), and 24.4% (n = 7101), respectively. After adjustment for age, gender, and use of antihypertensive medication, systolic/diastolic BP were significantly higher with cigarette smoking (n = 8070, +0.5/+1.0 mm Hg, p < 0.05), mild (n = 4369, +1.2/+1.3 mm Hg, p < 0.001) and moderate or heavy alcohol drinking (n = 3871, +0.4/+0.7 mm Hg, p < 0.05), and overweight (+1.8/+1.4 mm Hg, p < 0.001) and obesity (+2.3/+1.5 mm Hg, p < 0.001). In conclusion, our study provided unique blood pressure data during the COVID‐19 period, and suggested that hypertension management might have been even more challenging when the medical professionals had to shift their focus on other urgencies. |
| format | Article |
| id | doaj-art-5053410cbfcb48449b4e1793755b454d |
| institution | Kabale University |
| issn | 1524-6175 1751-7176 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | The Journal of Clinical Hypertension |
| spelling | doaj-art-5053410cbfcb48449b4e1793755b454d2025-01-31T05:38:36ZengWileyThe Journal of Clinical Hypertension1524-61751751-71762025-01-01271n/an/a10.1111/jch.14919May Measurement Month 2020: An Analysis of Blood Pressure Screening Results From ChinaXin Chen0Li‐Ping Zhang1Xiao‐Long Wang2Ning‐Ru Zhang3Jing Yu4Li‐Ying Xu5Tong‐She Li6Hong Luan7Juan Zhang8Ya‐Min Hu9Dan Liu10Qi‐Dong Zheng11Yan Li12Ji‐Guang Wang13Department of Cardiovascular Medicine The Shanghai Institute of Hypertension Ruijin Hospital, Shanghai Jiaotong University School of Medicine Shanghai ChinaDepartment of Internal Medicine Hospital of Shanxi Datong University Shanxi ChinaDepartment of Cardiology People's Hospital of Hongsibao District Ningxia ChinaDepartment of Cardiology The First Affiliated Hospital of Bengbu Medical University Anhui ChinaDepartment of Cardiology Lanzhou University Second Hospital Gansu ChinaDepartment of Cardiology The Forth People's Hospital of Datong City Shanxi ChinaDepartment of Cardiology Luoyang Dongfang People's Hospital Henan ChinaDepartment of Cardiology People's Hospital of Ningxia Hui Autonomous Region Ningxia ChinaDepartment of Cardiology The Second Affiliated Hospital of Zhengzhou University Henan ChinaDepartment of Cardiology Cangzhou Central Hospital Hebei ChinaDepartment of Cardiology The First People's Hospital of Zunyi Guizhou ChinaDepartment of Internal Medicine Yuhuan Second Peoples’ Hospital Zhejiang ChinaDepartment of Cardiovascular Medicine The Shanghai Institute of Hypertension Ruijin Hospital, Shanghai Jiaotong University School of Medicine Shanghai ChinaDepartment of Cardiovascular Medicine The Shanghai Institute of Hypertension Ruijin Hospital, Shanghai Jiaotong University School of Medicine Shanghai ChinaABSTRACT We reported the blood pressure data obtained in the May Measurement Month (MMM) China project in 2020 during the COVID‐19 control period. The study participants were adults (≥ 18 years), ideally in whom blood pressure had not been measured in the previous year. Blood pressure was measured three times consecutively with a 1‐min interval in the sitting position, using a validated automated BP monitor (Omron HEM‐7081IT), and transmitted to a central database via a smartphone app. The measurement was performed at 136 sites across 29 China provinces. The 100 728 participants had a mean (±SD) age of 45.6 (±18.3) years and included 56 097 (55.7%) women. The mean systolic/diastolic blood pressure was 120.0/76.9 mm Hg. The proportion of hypertension was 28.9% (n = 29 135), and the awareness, treatment, and control rates of hypertension were 45.3% (n = 13 212), 39.7% (n = 1573), and 24.4% (n = 7101), respectively. After adjustment for age, gender, and use of antihypertensive medication, systolic/diastolic BP were significantly higher with cigarette smoking (n = 8070, +0.5/+1.0 mm Hg, p < 0.05), mild (n = 4369, +1.2/+1.3 mm Hg, p < 0.001) and moderate or heavy alcohol drinking (n = 3871, +0.4/+0.7 mm Hg, p < 0.05), and overweight (+1.8/+1.4 mm Hg, p < 0.001) and obesity (+2.3/+1.5 mm Hg, p < 0.001). In conclusion, our study provided unique blood pressure data during the COVID‐19 period, and suggested that hypertension management might have been even more challenging when the medical professionals had to shift their focus on other urgencies.https://doi.org/10.1111/jch.14919blood pressurecontrolhypertensionscreeningtreatment |
| spellingShingle | Xin Chen Li‐Ping Zhang Xiao‐Long Wang Ning‐Ru Zhang Jing Yu Li‐Ying Xu Tong‐She Li Hong Luan Juan Zhang Ya‐Min Hu Dan Liu Qi‐Dong Zheng Yan Li Ji‐Guang Wang May Measurement Month 2020: An Analysis of Blood Pressure Screening Results From China The Journal of Clinical Hypertension blood pressure control hypertension screening treatment |
| title | May Measurement Month 2020: An Analysis of Blood Pressure Screening Results From China |
| title_full | May Measurement Month 2020: An Analysis of Blood Pressure Screening Results From China |
| title_fullStr | May Measurement Month 2020: An Analysis of Blood Pressure Screening Results From China |
| title_full_unstemmed | May Measurement Month 2020: An Analysis of Blood Pressure Screening Results From China |
| title_short | May Measurement Month 2020: An Analysis of Blood Pressure Screening Results From China |
| title_sort | may measurement month 2020 an analysis of blood pressure screening results from china |
| topic | blood pressure control hypertension screening treatment |
| url | https://doi.org/10.1111/jch.14919 |
| work_keys_str_mv | AT xinchen maymeasurementmonth2020ananalysisofbloodpressurescreeningresultsfromchina AT lipingzhang maymeasurementmonth2020ananalysisofbloodpressurescreeningresultsfromchina AT xiaolongwang maymeasurementmonth2020ananalysisofbloodpressurescreeningresultsfromchina AT ningruzhang maymeasurementmonth2020ananalysisofbloodpressurescreeningresultsfromchina AT jingyu maymeasurementmonth2020ananalysisofbloodpressurescreeningresultsfromchina AT liyingxu maymeasurementmonth2020ananalysisofbloodpressurescreeningresultsfromchina AT tongsheli maymeasurementmonth2020ananalysisofbloodpressurescreeningresultsfromchina AT hongluan maymeasurementmonth2020ananalysisofbloodpressurescreeningresultsfromchina AT juanzhang maymeasurementmonth2020ananalysisofbloodpressurescreeningresultsfromchina AT yaminhu maymeasurementmonth2020ananalysisofbloodpressurescreeningresultsfromchina AT danliu maymeasurementmonth2020ananalysisofbloodpressurescreeningresultsfromchina AT qidongzheng maymeasurementmonth2020ananalysisofbloodpressurescreeningresultsfromchina AT yanli maymeasurementmonth2020ananalysisofbloodpressurescreeningresultsfromchina AT jiguangwang maymeasurementmonth2020ananalysisofbloodpressurescreeningresultsfromchina |